These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3868221)

  • 1. [Characterization of the pathways of cefotiam elimination by clearance approaches in patients following cholecystectomy].
    Terziivanov D; Gerova Z; Vlakhov V
    Vutr Boles; 1985; 24(6):84-9. PubMed ID: 3868221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy.
    Terziivanov D; Gerova Z; Vlahov V; Merdzhanov A; Damjanov D
    Eur J Clin Pharmacol; 1986; 30(4):439-44. PubMed ID: 3462003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of the cephalosporin antibiotic cefotiam following its intravenous administration to patients after cholecystectomy].
    Terziivanov D; Gerova Z; Vlakhov V
    Vutr Boles; 1986; 25(6):86-91. PubMed ID: 3471005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetics of cefixime biliary clearance in cholecystectomized patients].
    Westphal JF; Jehl F; Brogard JM
    Therapie; 1994; 49(1):35-9. PubMed ID: 8091363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary elimination of cefotiam, an experimental and clinical study.
    Brogard JM; Arnaud JP; Blickle JF; Levy P; Dorner M; Lautier F
    Chemotherapy; 1986; 32(3):222-35. PubMed ID: 3458565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cefixime biliary disposition in the isolated perfused rabbit liver model and in humans.
    Westphal JF; Brogard JM; Jehl F; Schloegel M; Blickle JF; Monteil H
    Drugs Exp Clin Res; 1992; 18(8):329-36. PubMed ID: 1292915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].
    Farquet C; Marti MC; Balant L; Cochet B; Rudhardt M; Fabre J; Rohner A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):123-9. PubMed ID: 6461067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of azosemide in patients with T-drain after cholecystectomy.
    Schuchmann HW; Rösch W; Koch U; Maurer HH; Stengl U; Mutschler E
    Arzneimittelforschung; 1992 Jun; 42(6):812-4. PubMed ID: 1418035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary excretion of mezlocillin in patients with hepatic disease.
    Hildebrandt R; Gundert-Remy U; Raedsch R; Sieg A; Stiehl A
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies on excretion in biliary tract with the antibiotic cefotiam].
    Yaita A; Kanamori H; Masuo K; Taniura H; Nakamura T
    Jpn J Antibiot; 1985 Jun; 38(6):1566-70. PubMed ID: 3862879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of experimentally induced cholestasis on the pharmacokinetics of cefotiam.
    Alonso IG; Mariño EL; Dominguez-Gil A
    Arzneimittelforschung; 1984; 34(7):798-800. PubMed ID: 6093824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Piperacillin: pharmacokinetic studies on the biliary and renal excretion (author's transl)].
    Baier R; Puppel H; Zelder O; Zehner R
    Arzneimittelforschung; 1981; 31(5):857-61. PubMed ID: 6456008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biliary, renal and fecal elimination and distribution of gold after a single oral administration of auranofin, quantified by the instrumental neutron activation analysis method].
    Benn HP; Schnier C; Bauer E; Seiler KU; Elhöft H; Löffler H
    Z Rheumatol; 1991; 50(1):32-8. PubMed ID: 2058320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian rhythmic hepatic biliary flow, constituents, concentrations and excretory rates in patients after cholecystectomy.
    Ho KJ
    Chronobiologia; 1994; 21(3-4):283-92. PubMed ID: 7729244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary excretion of ceftizoxime in humans.
    Brogard JM; Arnaud JP; Timmler R
    Chemotherapy; 1984; 30(4):221-6. PubMed ID: 6086245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ceftriaxone, a cephalosporin with high hepatic elimination. Evaluation of its biliary clearance in man. Therapeutic value].
    Brogard JM; Jehl F; Paris-Bockel D; Sini F; Blickle JF; Adloff M; Monteil H
    Schweiz Med Wochenschr; 1987 Oct; 117(40):1549-59. PubMed ID: 3672089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ceftizoxime.
    Gundert-Remy U; Hildebrandt R; Stiehl A; Schlegel P
    Eur J Clin Pharmacol; 1985; 28(4):463-7. PubMed ID: 3861322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.
    Rouan MC; Binswanger U; Bammatter F; Theobald W; Schoeller JP; Guibert J
    J Antimicrob Chemother; 1984 Jun; 13(6):611-8. PubMed ID: 6088464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cefotiam excretion into the bile after radical operation of congenital biliary atresia].
    Miyano T; Arai T; Suruga K; Saionji M
    Jpn J Antibiot; 1983 Dec; 36(12):3429-36. PubMed ID: 6325753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humans.
    le Corre P; Malledant Y; Chevanne F; Sado P; le Verge R
    Chirality; 1992; 4(2):80-3. PubMed ID: 1616827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.